Indonesia

in page functions
[French]
Indonesia
Total population (2017) 263,509,438
Birth cohort (2017) 4,946,500
Surviving Infants (surviving to 1 year per year, 2017) 4,834,892
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 23/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 27/1000
Gross Nation Income (per capita US$, 2015) 3,440
Co-financing group (2017) Fully self-financing
No. of districts/territories (2016) 514

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Indonesia

Type of support

Approvals

2001-2021 (US$)
(18 Oct 2017)

Commitments

2001-2021 (US$)
(18 Oct 2017)

Disbursements

2000-2017 (US$)
(18 Oct 2017)

% Disbursed

(18 Oct 2017)
2002 2003 2004 2005 2006 2007 2008 2011 2012 2013 2014 2015 2016 2017 2018
Total $170,858,844 $179,107,844 $159,845,419
Cash Support (CASHSUPP) $170,000 $195,000 $170,000 100%
Civil Society Organisation support (CSO) $3,900,500 $3,900,500 $4,000,500 103%
Health system strengthening (HSS 1) $24,827,500 $24,827,500 $24,827,500 100%
HepB mono (NVS) $17,511,000 $17,511,000 $17,511,000 100%
HPV Demo (NVS) $97,500 $180,500 $98,075 101%
Immunisation services support (ISS) $12,636,000 $12,636,000 $12,636,000 100%
Injection Safety Devices (NVS) $163,500 $163,500 $163,500 100%
Injection safety support (INS) $9,856,844 $9,856,844 $9,856,844 100%
IPV (NVS) $10,812,000 $18,953,000 $10,812,000 100%
JEV (NVS) $343,500 $343,500
Measles-Rubella (NVS) $27,769,500 $27,769,500 $27,769,500 100%
Penta (NVS) $51,176,500 $51,176,500 $44,321,000 87%
Vaccine Introduction Grant (VIG) $11,594,500 $11,594,500 $7,679,500 66%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Indonesia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 84%
M:F sex ratio at birth (2017) 1.05
Household survey: DTP3 coverage for male (2011) 73.10%
Household survey: DTP3 coverage for female (2011) 70.90%
Household survey: Last DTP3 survey (2011) 72%
% districts achieving > 80% DTP3 coverage (2016) 74%
% districts achieving < 50% DTP3 coverage (2016) 4%
MCV WHO/UNICEF estimates (2016) 76%

Breakdown of support

Non-vaccine support Vaccine support
37% 63%
$59,170,344 $100,675,075

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Indonesia

26 October 2017

Malawi MR 2017

01 August 2017

President of Indonesia at the measles-rubella vaccine launch

Indonesian Government to immunise 70 million children against measles and rubella

The two-year campaign will aim to reach 95% immunisation coverage in Indonesia.

10 November 2016

Tanzania

Measles jab saves over 20 million young lives in 15 years, but hundreds of children still die of the disease every day

Measles outbreaks in numerous countries – caused by gaps in routine immunisation and in mass vaccination campaigns – continue to be a serious challenge.

close icon

modal window here